“Synergistic Growth Inhibition by Sorafenib and Vitamin K2 in Human Hepatocellular Carcinoma Cells”. Clinics 67, no. 9 (September 1, 2012): 1093–1099. Accessed April 27, 2024. https://www.revistas.usp.br/clinics/article/view/45877.